BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8094619)

  • 21. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products.
    Chen L; Zhang W; Fregien N; Pierce M
    Oncogene; 1998 Oct; 17(16):2087-93. PubMed ID: 9798679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
    Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
    Acta Oncol; 1992; 31(2):147-50. PubMed ID: 1352454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential processing and turnover of the oncogenically activated neu/erb B2 gene product and its normal cellular counterpart.
    Huang SS; Koh HA; Konish Y; Bullock LD; Huang JS
    J Biol Chem; 1990 Feb; 265(6):3340-6. PubMed ID: 1968062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.
    Russell KS; Hung MC
    Cancer Res; 1992 Dec; 52(23):6624-9. PubMed ID: 1358436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of fgf4 gene expression in the myotomes is regulated by myogenic bHLH factors and by sonic hedgehog.
    Fraidenraich D; Iwahori A; Rudnicki M; Basilico C
    Dev Biol; 2000 Sep; 225(2):392-406. PubMed ID: 10985858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Bargmann CI; Hung MC; Weinberg RA
    Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
    Lehtola L; Nistér M; Hölttä E; Westermark B; Alitalo K
    Cell Regul; 1991 Aug; 2(8):651-61. PubMed ID: 1685673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neu oncogene encodes an epidermal growth factor receptor-related protein.
    Bargmann CI; Hung MC; Weinberg RA
    Nature; 1986 Jan 16-22; 319(6050):226-30. PubMed ID: 3945311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation mechanism of specific expression of tumor marker gene during carcinogenesis].
    Imagawa M
    Yakugaku Zasshi; 1996 Jul; 116(7):505-18. PubMed ID: 8831256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun.
    Owen RD; Ostrowski MC
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3866-70. PubMed ID: 2111019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
    Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
    Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D; Shi D; Scanlon M; Hung MC
    Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of human hst expression by an enhancer element residing in the third exon.
    Sasaki A; Kubo M; Hasan S; Yano Y; Kakinuma M
    Jpn J Cancer Res; 1991 Nov; 82(11):1191-5. PubMed ID: 1836454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
    Weisz A; Rosales R
    Nucleic Acids Res; 1990 Sep; 18(17):5097-106. PubMed ID: 2119495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cells.
    McInerney JM; Wilson MA; Strand KJ; Chrysogelos SA
    J Cell Biochem; 2001; 80(4):538-49. PubMed ID: 11169738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
    Di Marco E; Pierce JH; Knicley CL; Di Fiore PP
    Mol Cell Biol; 1990 Jun; 10(6):3247-52. PubMed ID: 1971420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.